Patents Represented by Attorney William P. Majarian
  • Patent number: 6932972
    Abstract: Novel combined vaccine composition preferentially for administration to adolescents are provided, comprising a hepatitis B viral antigen and a herpes simplex viral antigen and optionally in addition one or more of the following: an EBV antigen, a hepatitis A antigen or inactivated attenuated virus, an HPV antigen, a V2V antigen, a HCMV antigen, a Toxoplasma gondii antigen. The vaccine compositions are formulated with an adjuvant which is a preferential stimulator of TH1 cell response such as 3D-MPL and QS21.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: August 23, 2005
    Assignee: SmithKline Beecham Biologicals S.A.
    Inventors: Jean Stephenne, Martine Anne Cecile Wettendorff